NuCana Plc (NCNA)
1.32
-0.02
(-1.49%)
USD |
NASDAQ |
Sep 11, 16:00
1.32
0.00 (0.00%)
After-Hours: 20:00
NuCana Enterprise Value : -19.30M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | -19.30M |
| September 10, 2026 | -19.22M |
| September 09, 2026 | -19.09M |
| September 08, 2026 | -18.96M |
| September 04, 2026 | -18.96M |
| September 03, 2026 | -18.83M |
| September 02, 2026 | -19.00M |
| September 01, 2026 | -19.05M |
| August 31, 2026 | -18.66M |
| August 28, 2026 | -17.41M |
| August 27, 2026 | -18.66M |
| August 26, 2026 | -18.40M |
| August 25, 2026 | -18.66M |
| August 24, 2026 | -18.66M |
| August 21, 2026 | -18.44M |
| August 20, 2026 | -18.40M |
| August 19, 2026 | -18.31M |
| August 18, 2026 | -18.44M |
| August 17, 2026 | -18.31M |
| August 14, 2026 | -18.14M |
| August 13, 2026 | -18.62M |
| August 12, 2026 | -18.83M |
| August 11, 2026 | -18.79M |
| August 10, 2026 | -18.79M |
| August 07, 2026 | -18.66M |
| Date | Value |
|---|---|
| August 06, 2026 | -19.13M |
| August 05, 2026 | -19.22M |
| August 04, 2026 | -19.00M |
| August 03, 2026 | -19.18M |
| July 31, 2026 | -19.30M |
| July 30, 2026 | -19.56M |
| July 29, 2026 | -19.78M |
| July 28, 2026 | -19.43M |
| July 27, 2026 | -19.56M |
| July 24, 2026 | -19.43M |
| July 23, 2026 | -19.26M |
| July 22, 2026 | -19.13M |
| July 21, 2026 | -19.43M |
| July 20, 2026 | -19.35M |
| July 17, 2026 | -19.33M |
| July 16, 2026 | -19.26M |
| July 15, 2026 | -19.18M |
| July 14, 2026 | -19.35M |
| July 13, 2026 | -19.48M |
| July 10, 2026 | -19.22M |
| July 09, 2026 | -19.65M |
| July 08, 2026 | -19.30M |
| July 07, 2026 | -19.00M |
| July 06, 2026 | -19.00M |
| July 02, 2026 | -19.13M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 15.61M |
| Silence Therapeutics Plc | 495.01M |
| BioNTech SE | 7.766B |
| Compass Pathways Plc | 1.569B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.134M |
| Total Expenses (Quarterly) | 4.134M |
| EPS Diluted (Quarterly) | -1.007 |
| Earnings Yield | -243.9% |
| Normalized Earnings Yield | -237.54 |